S-1 (tegafur/gimeracil/oteracil)

tegafur/gimeracil/oteracil · Taiho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for S-1 (tegafur/gimeracil/oteracil), covering 2024-04-29 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1 [Phase 3]

See pricing